Tue Oct 01 04:45:12 UTC 2024: ## VBI Vaccines Stock Drops 5.1% in Mid-Day Trading

**Toronto, October 1, 2024** – Shares of VBI Vaccines Inc. (TSE: VBV) fell 5.1% in mid-day trading on Monday, closing at C$4.82. The stock traded as low as C$4.82, with only 1,300 shares changing hands – a significant decrease from the average daily volume of 3,637 shares. This decline comes after the stock closed at C$5.08 the previous day.

VBI Vaccines is a biopharmaceutical company focused on developing and marketing vaccines for infectious diseases and immuno-oncology. Its portfolio includes Sci-B-Vac, a third-generation hepatitis B vaccine, and eVLP, a platform for creating virus-like particle vaccines.

The company currently has a market cap of C$308.86 million and a P/E ratio of -4.97. Its financial ratios include a debt-to-equity ratio of 14.29, a current ratio of 2.64, and a quick ratio of 2.54.

While the reason for the stock’s decline is not explicitly stated, it may be influenced by broader market trends or investor sentiment. However, this news comes after VBI Vaccines announced a significant milestone in its development of a new vaccine for COVID-19.

**Other Market News**

In other market news, Avcorp Industries (TSE: AVP) traded down 4.5% and Alaska Power & Telephone (OTCMKTS: APTL) saw a decline of 0.8%.

Read More